These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6159320)

  • 41. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
    Milisauskas VK; Kaminsky SG; Nakamura I
    Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
    Höglund P; Ljunggren HG; Ohlén C; Ahrlund-Richter L; Scangos G; Bieberich C; Jay G; Klein G; Kärre K
    J Exp Med; 1988 Oct; 168(4):1469-74. PubMed ID: 3171481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
    Rosenberg AS; Singer A
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced positive selection of a transgenic TCR by a restriction element that does not permit negative selection.
    Ohashi PS; Zinkernagel RM; Leuscher I; Hengartner H; Pircher H
    Int Immunol; 1993 Feb; 5(2):131-8. PubMed ID: 8452813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
    Kanamoto A; Maki T
    J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):31-41. PubMed ID: 6826208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Provocation of skin graft rejection across murine class II differences by non--bone-marrow-derived cells.
    Stuart PM; Beck-Maier B; Melvold RW
    Transplantation; 1984 Apr; 37(4):393-6. PubMed ID: 6369671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
    Daley JP; Nakamura I
    J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asymmetry in the serological response and mixed lymphocyte reactions between C57Bl/6 and the congenic mutant C57Bl/6.CH-2ba [H(Zl)].
    Chauvenet PH; Amos DB; Smith RT
    J Immunogenet; 1978 Jun; 5(3):179-91. PubMed ID: 151119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reactivity of the B6.C-H-2bm-1 mutant to the wild-type tumor EL4: characterization of the serological response.
    Saunders PH; Very DL; Lawlor DA
    Cell Immunol; 1983 Mar; 76(2):332-9. PubMed ID: 6839364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver tissue graft rejection in murine major histocompatibility complex mutants.
    Schultz JS; DeMott-Friberg R; Beals TF
    Immunogenetics; 1982; 15(4):357-64. PubMed ID: 6210632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.
    Nell LJ; Cook RG; Rich RR
    Transplantation; 1982 Jul; 34(1):54-9. PubMed ID: 6181592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice.
    Frels WI; Bluestone JA; Hodes RJ; Capecchi MR; Singer DS
    Science; 1985 May; 228(4699):577-80. PubMed ID: 3885396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An X-encoded alloantigenicity between BALB/c and C57BL/6 strains of mice.
    Alner KA; Loman J; Hall EH; Mutcherson RJ; King TR
    Immunogenetics; 2003 May; 55(2):87-94. PubMed ID: 12698287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.